Can you get 5 doses out of a Mounjaro pen?

What the licensed pen specification says, and why the number four is fixed

The Mounjaro SmPC, published on the electronic Medicines Compendium, specifies each KwikPen as a four-dose device. The pen is pre-filled with a volume calculated to deliver four subcutaneous injections at the stated concentration for that strength. There is no hidden reservoir. Once the four doses are spent, the plunger reaches the end of its travel and the pen locks. That locking mechanism is a safety feature, not a manufacturing oversight.

You may have read on forums that residual liquid is visible through the pen's window after the fourth dose. That residue exists, but it is not a usable fifth dose, it is the overfill that pharmaceutical manufacturers include to guarantee the four labelled doses are delivered in full, accounting for small variations in the injection process. How Mounjaro's pen doses work in practice is a question our prescribers hear regularly, and the consistent answer from the clinical evidence is straightforward: four doses, used once weekly, as prescribed.

The MHRA-approved Mounjaro SmPC on the eMC describes the administration schedule in full. Following it precisely is the basis on which the SURMOUNT-1 trial (the study that reported average body-weight reductions of around 20–21% at the 15 mg dose over 72 weeks) was designed and conducted.

Why a fifth dose attempt falls short in practice

It is worth being honest about why people ask this question. Mounjaro is not cheap, and a pen that might yield one more injection feels like a reasonable thing to try. That instinct is understandable. But here is what actually happens when the pen's four doses are used: the plunger mechanism reaches its physical stop, the needle retracts, and the device locks to prevent reuse. Even before that lock engages, the remaining overfill volume is not uniform, it varies between pens and is not concentrated at the tip in a way that would allow a reliable subcutaneous injection.

Attempting to manipulate a spent pen to draw liquid can damage the delivery mechanism, introduce air into the dose, or result in a partial injection that is impossible to measure. For a medicine that is titrated in precise milligram steps (starting at 2.5 mg and increasing on a structured schedule) an unmeasured partial dose is clinically meaningless at best. Our full Mounjaro overview explains why dose accuracy underpins the titration schedule.

There is also a practical supply point: if the pen appears to have liquid left after four uses, that does not mean a dose was missed. Each injection dispenses the calibrated volume, and the visual window is not a precise measuring tool. If you are genuinely unsure whether a dose was fully delivered, speak to your prescriber rather than attempting a repeat from the same pen.

What to do if supply timing is the real concern

The question of whether you can get five doses from a Mounjaro pen is sometimes really a question about what to do when your next pen has not arrived in time. This is a different problem, and one with clearer solutions. First, check whether a missed or delayed dose is covered by the guidance in your Patient Information Leaflet, for a once-weekly injection, timing windows for late doses are addressed there. Second, contact your pharmacy or prescriber promptly; do not attempt to ration doses by taking them less frequently than prescribed without clinical advice, because the titration schedule exists for a reason.

At nume, orders placed by 12pm Monday to Friday are dispatched the same day once clinically approved, with free next-working-day tracked delivery, specifically so patients are not left managing supply gaps. For context on how Mounjaro treatment is priced as a complete package, Mounjaro's cost in the UK covers what transparent, all-inclusive pricing actually looks like versus headline-only figures.

If you are approaching the end of a pen and your next supply is not confirmed, the right call is to get in touch with our team early. Our prescribers review repeat orders before dispatch, not as a formality, but because a clinical check at each stage is part of how safe, evidence-based treatment works. You can read more about the clinical team's approach on our prescribers' profile page.

Thinking about starting or switching? What the evidence says about dose selection

If this question came up because you are wondering whether a lower-strength pen can be used to approximate a higher dose (for example, by taking an extra injection from a 2.5 mg pen) the answer is also no, and for additional reasons. Using two injections from the same pen would still exceed the four-dose design limit, and self-escalating dose without prescriber authorisation falls outside the licensed treatment pathway entirely.

The question of moving directly to 5 mg Mounjaro is one a prescriber assesses individually, based on tolerance of the starter dose and clinical history. Similarly, taking two doses of Mounjaro in any form (whether from one pen or two) is not part of the licensed schedule and carries real safety implications. The NHS's patient information on tirzepatide sets out the approved dosing framework clearly, and it starts from the same premise: one dose, once a week, from a pen designed to deliver four of them.

If you have questions about your current dose, your next pen, or whether the treatment is still the right fit for you, a consultation is the right place to start. Prescription medicines work best when the dosing stays clinical.